Introduction:
The global biologics market is experiencing significant growth, with an increasing focus on patient advocacy groups that play a crucial role in supporting patients and raising awareness about biologics. According to a recent report, the global biologics market is expected to reach $399.5 billion by 2026. In this report, we will discover the top 10 global biologics patient advocacy groups that are making a difference in the industry.
Top 10 Global Biologics Patient Advocacy Groups 2026:
1. American Autoimmune Related Diseases Association (AARDA)
– AARDA is a leading patient advocacy group in the United States, dedicated to raising awareness about autoimmune diseases and supporting patients through education and research initiatives.
2. European Organisation for Rare Diseases (EURORDIS)
– EURORDIS is a prominent patient advocacy group in Europe, focusing on rare diseases and advocating for better access to treatment and care for patients.
3. Canadian Organization for Rare Disorders (CORD)
– CORD is a key player in Canada, advocating for patients with rare disorders and working to improve healthcare policies and services for those in need.
4. National Psoriasis Foundation (NPF)
– NPF is a well-known advocacy group in the field of dermatology, providing support and resources to patients with psoriasis and psoriatic arthritis.
5. Global Genes
– Global Genes is an international advocacy organization, dedicated to raising awareness about rare genetic diseases and empowering patients and families through education and support programs.
6. Arthritis Foundation
– The Arthritis Foundation is a leading organization in the fight against arthritis, providing resources, advocacy, and support to millions of patients worldwide.
7. Crohn’s & Colitis Foundation
– This foundation is dedicated to improving the quality of life for patients with inflammatory bowel diseases, such as Crohn’s disease and ulcerative colitis, through research, education, and advocacy efforts.
8. Leukemia & Lymphoma Society
– The Leukemia & Lymphoma Society is a major player in the field of blood cancers, funding research, supporting patients, and advocating for better treatments and cures.
9. Cystic Fibrosis Foundation
– The Cystic Fibrosis Foundation is committed to finding a cure for cystic fibrosis and improving the lives of patients through research, advocacy, and care programs.
10. Lung Cancer Alliance
– The Lung Cancer Alliance is a leading advocacy organization in the fight against lung cancer, working to raise awareness, support patients, and promote early detection and treatment options.
Insights:
The role of patient advocacy groups in the biologics industry is becoming increasingly important, as they play a key role in supporting patients, raising awareness, and advocating for better treatment options. As the global biologics market continues to expand, these advocacy groups will be instrumental in shaping healthcare policies, driving research initiatives, and improving patient outcomes. According to recent forecasts, the biologics market is projected to grow at a CAGR of 8.5% from 2021 to 2026, indicating a promising future for both the industry and patient advocacy groups. By collaborating with these top 10 global biologics patient advocacy groups, pharmaceutical companies and healthcare providers can enhance their efforts to support patients and advance the field of biologics.
Related Analysis: View Previous Industry Report
